
USD
$0.00
(0.00%
)At Close (As of Nov 26, 2025)
$1.98B
Market Cap
-
P/E Ratio
-2.8
EPS
$72.33
52 Week High
$26.55
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $110M |
| Total Revenue | $166M |
| Cost Of Revenue | $57M |
| Costof Goods And Services Sold | $57M |
| Operating Income | -$50M |
| Selling General And Administrative | $140M |
| Research And Development | $20M |
| Operating Expenses | $160M |
| Investment Income Net | - |
| Net Interest Income | -$19M |
| Interest Income | $1.5M |
| Interest Expense | $21M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $7.6M |
| Income Before Tax | -$85M |
| Income Tax Expense | -$32K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$85M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$64M |
| Ebitda | -$56M |
| Net Income | -$85M |
| Field | Value (USD) |
|---|---|
| Total Assets | $347M |
| Total Current Assets | $243M |
| Cash And Cash Equivalents At Carrying Value | $90M |
| Cash And Short Term Investments | $90M |
| Inventory | $79M |
| Current Net Receivables | $65M |
| Total Non Current Assets | $104M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $12M |
| Intangible Assets Excluding Goodwill | $12M |
| Goodwill | $1.2M |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $8.9M |
| Other Non Current Assets | - |
| Total Liabilities | $294M |
| Total Current Liabilities | $68M |
| Current Accounts Payable | $45M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $1.5M |
| Total Non Current Liabilities | $225M |
| Capital Lease Obligations | $5.7M |
| Long Term Debt | $220M |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $225M |
| Other Current Liabilities | $20M |
| Other Non Current Liabilities | $102K |
| Total Shareholder Equity | $53M |
| Treasury Stock | - |
| Retained Earnings | -$445M |
| Common Stock | $420M |
| Common Stock Shares Outstanding | $28M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$59M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $7.6M |
| Capital Expenditures | $16M |
| Change In Receivables | - |
| Change In Inventory | -$471K |
| Profit Loss | - |
| Cashflow From Investment | -$16M |
| Cashflow From Financing | $126M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$85M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $110M |
| Total Revenue | $166M |
| Cost Of Revenue | $57M |
| Costof Goods And Services Sold | $57M |
| Operating Income | -$50M |
| Selling General And Administrative | $140M |
| Research And Development | $20M |
| Operating Expenses | $160M |
| Investment Income Net | - |
| Net Interest Income | -$19M |
| Interest Income | $1.5M |
| Interest Expense | $21M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $7.6M |
| Income Before Tax | -$85M |
| Income Tax Expense | -$32K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$85M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$64M |
| Ebitda | -$56M |
| Net Income | -$85M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Establishment Labs Holdings Inc. is a leading medical technology company headquartered in Alajuela, Costa Rica, specializing in innovative solutions for the aesthetic and reconstructive plastic surgery markets. The company's portfolio includes advanced medical devices designed with a strong emphasis on quality, safety, and patient care. Through a steadfast commitment to research and development, Establishment Labs continuously enhances its offerings to align with the evolving needs of surgeons and patients alike. By positioning itself as a key player in the global aesthetic medical landscape, the company is poised for significant growth and continued impact on the industry.